NCT06190886View on ClinicalTrials.gov

A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

June 11, 2024

Primary Completion Date

May 14, 2026

Study Completion Date

July 24, 2026

Conditions
Advanced CancerSolid TumorMetastatic Cancer
Interventions
DRUG

PTX-912

Investigation Product Monotherapy

Trial Locations (3)

33136

RECRUITING

University of Miami, Miami

68130

RECRUITING

Nebraska Cancer Specialists (NCS), Omaha

91010

RECRUITING

City of Hope National Medical Center, Duarte

All Listed Sponsors
lead

Proviva Therapeutics, Inc.

INDUSTRY